Clin2
NCT07499583Possibly a fitNot yet recruiting

Psilocybin therapy for depression and substance use in veterans and first responders

Treatment Resistant DepressionSubstance Use Disorders

Treatments studied

Part of Mental health clinical trials.

This trial tests whether psilocybin-assisted psychotherapy can help veterans and first responders with treatment-resistant depression and a co-occurring substance use disorder. It aims to see if this approach reduces depression and substance use.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
50 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a veteran or first responder, and at least 18 years old but not older than 70.
  • You have major depression that has not improved after trying at least two different antidepressants.
  • You have moderate or severe use of alcohol, cocaine, opioids, heroin, or cannabis, though nicotine and mild recreational use of other substances are okay.
  • You can read and understand English, and you are in good enough physical health to safely receive an MRI.
  • You have not had a serious suicide attempt or have current suicidal thoughts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06378229Recruiting· Phase 2
Psilocybin for hospitalized treatment-resistant depression

This trial tests whether a single dose of psilocybin can help hospitalized patients with tough-to-treat depression. It focuses on people who haven't improved with standard antidepressants and need a new option.

Ghent, Oost-Vlaanderen
NCT07183748Recruiting· Phase 2
Psilocybin microdosing plus therapy for hard-to-treat depression

This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.

Beersheba
NCT06512220Recruiting· Phase 2
Psilocybin for treatment-resistant depression brain imaging study

This study tests whether a psilocybin-based treatment can help people with depression that has not improved after trying several antidepressants. You will receive the study treatment and have brain scans to see how it affects brain connections.

Toronto, Ontario
NCT07226232Recruiting· Phase 3
Psilocybin for veterans with treatment-resistant depression

This study tests whether psilocybin (a psychedelic substance) can help veterans with depression that hasn't improved with standard treatments.

Birmingham, Alabama
NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT07703722Recruiting· Phase 3
Psilocybin and therapy for depression with trauma

This trial tests psilocybin (a compound from certain mushrooms) combined with a structured therapy to see if it helps people with depression linked to trauma. It focuses on how the treatment affects the connection between the gut and brain.

Islamabad, Capital

Hear when a new Treatment Resistant Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.